| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/18/2023 | Genprex, Inc. | GNPX | Grant | Common Stock | 245k | $0.00 | $0 | | 02/18/2023 |
| 02/04/2022 | Genprex, Inc. | GNPX | Grant | Stock Option (right to buy) | 98.8k | $2.20 | $217.2k | | 02/04/2022 |
| 09/27/2021 | Genprex, Inc. | GNPX | Grant | | 550k | $2.85 | $1.6M | | 09/27/2021 |
| 09/01/2021 | Actinium Pharmaceuticals, Inc. | ATNM | Grant | Stock Option (Right to Buy) | 67.2k | $0.00 | $0 | | 09/01/2021 |
| 08/12/2020 | Actinium Pharmaceuticals, Inc. | ATNM | Grant | Stock Option (Right to Buy) | 46.7k | $0.00 | $0 | | 08/12/2020 |
| 07/12/2019 | Actinium Pharmaceuticals, Inc. | ATNM | Grant | Options to purchase common stock | 400k | $0.23 | $92.8k | | 07/12/2019 |
| 03/05/2019 | Actinium Pharmaceuticals, Inc. | ATNM | Exercise (in-the-money or at-the-money) | Common Stock | 3.5k | $0.60 | $2.1k | | 03/05/2019 |
| 07/13/2018 | Actinium Pharmaceuticals, Inc. | ATNM | Grant | Options to purchase common stock | 250k | $0.78 | $195.7k | | 07/13/2018 |
| 03/06/2018 | Actinium Pharmaceuticals, Inc. | ATNM | Other (acquisition) | Series A Warrants | 3.5k | $0.60 | $2.1k | | 03/06/2018 |
| 03/06/2018 | Actinium Pharmaceuticals, Inc. | ATNM | Other (acquisition) | Common Stock | 14k | $0.50 | $7k | | 03/06/2018 |
| 03/06/2018 | Actinium Pharmaceuticals, Inc. | ATNM | Other (acquisition) | Series B Warrants | 10.5k | $0.70 | $7.4k | | 03/06/2018 |